These significant associations are in agreement with the prominent effect of TIPRL with LC3 and CD133 on diagnostic patients with grade 1 iCCA and with the superior efficiency of four variables, excluding CD46, on prognosticating with grade 1 HCCs and iCCA. The gene discussed is MAP1LC3A; the disease is infantile convulsions and choreoathetosis.